Multiple myeloma with simultaneous cutaneous and central nervous system involvement

Area of Science:

• Hematology
• Oncology
• Dermatology

Background:

• Multiple myeloma is a hematologic malignancy primarily affecting plasma cells.
• Cutaneous involvement, though rare, represents a significant clinical manifestation.

Observation:

• Skin lesions in multiple myeloma are infrequently recognized and often appear late in the disease.
• This late-stage manifestation is associated with aggressive disease biology.

Findings:

• Pathologic examination is crucial for diagnosing cutaneous involvement in multiple myeloma.
• The presence of skin lesions indicates a poor prognosis.

Implications:

• Further research is needed to establish effective treatment protocols for patients with cutaneous multiple myeloma.
• Early recognition and diagnosis of skin involvement may improve patient outcomes.